Nicolaus A. Wagner‐Bartak

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

Michael Wang, Luis Fayad, Nicolaus A. Wagner‐Bartak et al. · The Lancet Oncology · 2012 · 296 citations

Phase 1/2, Lymphoid Neoplasia, Hematological Malignancy +8

Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial

Michael Wang, Hun Ju Lee, Hubert H. Chuang et al. · The Lancet Oncology · 2015 · 212 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +6

Image Quality Assessment of Abdominal CT by Use of New Deep Learning Image Reconstruction: Initial Experience

Corey T. Jensen, Xinming Liu, Eric P. Tamm et al. · American Journal of Roentgenology · 2020 · 209 citations

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial

M Wang, Nathan Fowler, Nicolaus A. Wagner‐Bartak et al. · Leukemia · 2013 · 203 citations

Lymphoid Neoplasia, Medicine, Malignant Blood Disorder +6

Reduced-Dose Deep Learning Reconstruction for Abdominal CT of Liver Metastases

Corey T. Jensen, Shiva Gupta, Mohammed Saleh et al. · Radiology · 2022 · 94 citations · Full text